Purchase Order HHSN302201500086P

Award Date 8/14/15
Potential Completion Date 8/13/16
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $118,993 firm fixed price purchase order to Metabolon, Inc. to conduct research analyzing the metabolomic profile associated with cardiometabolic traits in African Americans. The contract has a period of performance from August 29, 2023 through August 28, 2024. Under the solicitation seeking this analysis, Metabolon will leverage its expertise in metabolomics to provide...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
Metabolon, Inc., a small disadvantaged business, was awarded a $244,993.28 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute. The purpose is to perform metabolomic profiling of individuals of African descent with metabolic disorders, including a focus on comparing the metabolic profiles of those with high versus low triglyceride levels. This award is part of the Africa America Diabetes study and aims to integrate multiple omics...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...
This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...
This is a $75,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Human Metabolome Technologies America, Inc., a self-certified small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics profiling services, which includes conducting metabolomic assays, lipidomic analyses, and targeted metabolomics on samples related to various areas of...

Metabolite Laboratories, Inc. was awarded a $5,000 purchase order contract by the National Institutes of Health's National Human Genome Research Institute to provide unspecified products or services in support of genomic research efforts. With a period of performance of August 14, 2015 through August 13, 2016 and firm fixed pricing, this contract leveraged the NIH's Scientific Management Review Board vehicle to procure needed capabilities for the agency's human genome initiatives. No subcontractors or set aside designations were identified. The award supports the NIH's ongoing work to advance genomic and personalized medicine.

Generated 12/30/23, 9:54 AM